ZeroStack Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ZeroStack Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.68M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $35.87M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $76.07M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $33.40M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $8.98M | Mar 31, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.65M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.20M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $17.74M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $13.25M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.43M | Mar 31, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($15.91M) | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | ($57.04M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($52.42M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($21.36M) | Mar 31, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($154.65M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($8.93M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($50.35M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($47.22M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($19.00M) | Mar 31, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $418.0K | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | $62.0K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $388.0K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $132.0K | Mar 31, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.68M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($5.03M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($8.40M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($15.94M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($20.94M) | Mar 31, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.0K | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $134.0K | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $163.0K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.29M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $3.98M | Mar 31, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $130.24M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $26.23M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $23.63M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $80.99M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $85.48M | Mar 31, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.68M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $21.72M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $17.22M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $24.58M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $8.54M | Mar 31, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $70.55M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.51M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $6.40M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $56.82M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $77.17M | Mar 31, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.01M | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Mar 24, 2025 |
| FY2024 | Dec 31, 2022 | $23.37M | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | $19.68M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $430.0K | Mar 31, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($277.79M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($158.14M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($142.55M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($90.87M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($38.54M) | Mar 31, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.60M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.22M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $4.35M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $8.94M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $37.61M | Mar 31, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.49M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.08M | Feb 27, 2026 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (43) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | (50) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | (7) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | (13) | Mar 28, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (43) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | (50) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | (7) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | (13) | Mar 28, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.05M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 478,000 | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 8.94M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 6.78M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 65,517 | Mar 31, 2023 |